Enseval Putera Megatrading Tbk PT operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Enseval Putera Megatrading Tbk PT with three other
drug stores in Asia:
Luyan Pharma Co Ltd
sales of 8.34 billion Chinese Renmimbi [US$1.29 billion]
of which 94%
was Pharmaceutical Wholesale),
Guangxi Liuzhou Pharmaceutical Co Ltd
(9.45 billion Chinese Renmimbi [US$1.46 billion]
of which 90%
was Wholesale), and
Hokuyaku Takeyama Holdings, Inc
based in Japan
(228.71 billion Japanese Yen [US$2.08 billion]
of which 70%
was Pharmaceutical Business).
Enseval Putera Megatrading Tbk PT reported sales of 19.67 trillion Indonesian Rupiahs (US$1.41 billion)
December of 2017.
increase of 3.9%
versus 2016, when the company's sales were 18.94 trillion Indonesian Rupiahs.
Sales at Enseval Putera Megatrading Tbk PT have increased during each of the previous five years
(and since 2012, sales have increased a total of 47%).
Sales of Pharmaceuticals saw an increase
5.5% in 2017, from
8.06 trillion Indonesian Rupiahs to 8.50 trillion Indonesian Rupiahs.